Beigene Stock Today
| BGNE Stock | USD 131.86 2.19 1.63% |
Performance0 of 100
| Odds Of DistressLess than 13
|
BeiGene is trading at 131.86 as of the 18th of April 2024, a -1.63 percent down since the beginning of the trading day. The stock's lowest day price was 131.28. BeiGene has less than a 13 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for BeiGene are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 3rd of February 2016 | Category Healthcare | Classification Health Care |
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. BeiGene, Ltd. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. Beigene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 104.49 M outstanding shares of which 1.73 M shares are currently shorted by private and institutional investors with about 7.43 trading days to cover. More on BeiGene
Moving together with BeiGene Stock
| 0.71 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.66 | GRTX | Galera Therapeutics Financial Report 9th of May 2024 | PairCorr |
Moving against BeiGene Stock
| 0.43 | EWTX | Edgewise Therapeutics Downward Rally | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 2nd of May 2024
BeiGene Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BeiGene's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BeiGene or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman CoFounder | Xiaodong Wang | ||||
| Thematic Idea | Cancer Fighters (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, ARCA Biotechnology, NASDAQ Composite, NASDAQ Health Care, Cancer Fighters, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering BeiGene report their recommendations after researching BeiGene's financial statements, talking to executives and customers, or listening in on BeiGene's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering BeiGene. The BeiGene consensus assessment is calculated by taking the average forecast from all of the analysts covering BeiGene. | |||||
BeiGene's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to BeiGene's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand BeiGene's financial leverage. It provides some insight into what part of BeiGene's total assets is financed by creditors.
| |||||
BeiGene (BGNE) is traded on NASDAQ Exchange in USA. It is located in 94 Solaris Avenue, Grand Cayman, Cayman Islands, KY1-1108 and employs 10,600 people. BeiGene is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 14.97 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BeiGene's market, we take the total number of its shares issued and multiply it by BeiGene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BeiGene conducts business under Biotechnology sector and is part of Health Care industry. The entity has 104.49 M outstanding shares of which 1.73 M shares are currently shorted by private and institutional investors with about 7.43 trading days to cover.
BeiGene currently holds about 5.7 B in cash with (1.16 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 55.17.
Check BeiGene Probability Of Bankruptcy
Ownership AllocationBeiGene retains a total of 104.49 Million outstanding shares. 30% of BeiGene outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check BeiGene Ownership Details
BeiGene Stock Price Odds Analysis
What are BeiGene's target price odds to finish over the current price? Based on a normal probability distribution, the odds of BeiGene jumping above the current price in 90 days from now is about 99.0%. The BeiGene probability density function shows the probability of BeiGene stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.9378 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, BeiGene will likely underperform. Additionally, beiGene has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of BeiGene to move above the current price in 90 days from now is about 99.0 (This BeiGene probability density function shows the probability of BeiGene Stock to fall within a particular range of prices over 90 days) .
BeiGene Stock Institutional Holders
Institutional Holdings refers to the ownership stake in BeiGene that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of BeiGene's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing BeiGene's value.| Instituion | Recorded On | Shares | |
| Amvescap Plc. | 2023-12-31 | 475.9 K | |
| Goldman Sachs Group Inc | 2023-12-31 | 428.7 K | |
| Artal Group S A | 2023-12-31 | 404.5 K | |
| Public Investment Fund | 2023-12-31 | 354.4 K | |
| First Trust Advisors L.p. | 2023-12-31 | 219.7 K | |
| Bank Of America Corp | 2023-12-31 | 176.4 K | |
| Capital International Sarl | 2023-12-31 | 176.3 K | |
| M&g Investment Management Ltd | 2023-12-31 | 173.3 K | |
| Baird Financial Group, Inc. | 2023-12-31 | 164.9 K | |
| Baker Bros Advisors Lp | 2023-12-31 | 10.6 M | |
| Capital Research & Mgmt Co - Division 3 | 2023-12-31 | 6.3 M |
BeiGene Historical Income Statement
BeiGene Income Statement is one of the three primary financial statements used for reporting BeiGene's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of BeiGene revenue and expense. BeiGene Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, BeiGene's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 1.5 B, whereas Net Loss is forecasted to decline to (1 B). View More FundamentalsBeiGene Stock Against Markets
Picking the right benchmark for BeiGene stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BeiGene stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BeiGene is critical whether you are bullish or bearish towards BeiGene at a given time. Please also check how BeiGene's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in BeiGene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
BeiGene Corporate Directors
BeiGene corporate directors refer to members of a BeiGene board of directors. The board of directors generally takes responsibility for the BeiGene's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of BeiGene's board members must vote for the resolution. The BeiGene board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Thomas Malley | Non-Executive Independent Director | Profile | |
| Qingqing Yi | Director | Profile | |
| Timothy Chen | Director | Profile | |
| Ke Tang | Director | Profile |
How to buy BeiGene Stock?
Before investing in BeiGene, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in BeiGene. To buy BeiGene stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of BeiGene. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase BeiGene stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located BeiGene stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased BeiGene stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as BeiGene, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy BeiGene Stock please use our How to Invest in BeiGene guide.
Already Invested in BeiGene?
The danger of trading BeiGene is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of BeiGene is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than BeiGene. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile BeiGene is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for BeiGene Stock analysis
When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is BeiGene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.45) | Revenue Per Share 23.554 | Quarterly Revenue Growth 0.669 | Return On Assets (0.12) | Return On Equity (0.22) |
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.